Sfoglia per Autore
Effect of glucose stress conditions in BL6T murine melanoma cells
2004 S. Cedrola, R. Cardani, C.A.M. La Porta
Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy
2004 R. Cardani, E. Mancinelli, V. Sansone, G. Rotondo, G. Meola
Proximal myotonic dystrophy mimicking progressive muscular atrophy
2005 G. Rotondo, V. Sansone, R. Cardani, E. Mancinelli, R. Krahe, D. Stangalini, G. Meola
Colocalization of ribonuclear inclusions and MBNL1 foci with no impairment of muscle differentiation in DM2
2005 G. Meola, R. Cardani, E. Mancinelli, G. Rotondo
BRAF V599E mutation occurs in Spitz and Reed nevi
2006 C. La Porta, R. Cardani, F. Facchetti, P. Presicce, S. Rao, E. Privitera, C. Clemente, M. C. Mihm
Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2
2006 R. Cardani, E. Mancinelli, G. Rotondo, V. Sansone, G. Meola
Muscleblind-like protein 1 nuclear sequestration and splicing pattern in myotonic dystrophy type 2
2006 R. Cardani, E. Mancinelli, A. Botta, G. Novelli, G. Meola
A putative role of ribonuclear inclusions and MBNL1 in the impairment of gallbladder smooth muscle contractility with cholelithiasis in myotonic dystrophy type 1
2008 R. Cardani, E. Mancinelli, G. Saino, L. Bonavina, G. Meola
Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2
2009 R. Cardani, S. Baldassa, A. Botta, F. Rinaldi, G. Novelli, E. Mancinelli, G. Meola
RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2 : an immunocytochemical study
2009 F. Perdoni, M. Malatesta, R. Cardani, M. Giagnacovo, E. Mancinelli, G. Meola, C. Pellicciari
Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways
2010 F. Rusconi, E. Mancinelli, G. Colombo, R. Cardani, L. Da Riva, I. Bongarzone, G. Meola, R. Zippel
Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2
2012 M. Giagnacovo, M. Malatesta, R. Cardani, G. Meola, C. Pellicciari
Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2
2012 R. Cardani, M. Giagnacovo, A. Botta, F. Rinaldi, A. Morgante, B. Udd, O. Raheem, S. Penttilä, T. Suominen, L.V. Renna, V. Sansone, E. Bugiardini, G. Novelli, G. Meola
Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2
2013 R. Cardani, E. Bugiardini, L.V. Renna, G. Colombo, R. Valaperta, G. Novelli, A. Botta, G. Meola
Plasma microRNAs as biomarkers for myotonic dystrophy type 1
2014 A. Perfetti, S. Greco, E. Bugiardini, R. Cardani, P. Gaia, C. Gaetano, G. Meola, F. Martelli
Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2
2014 R. Cardani, M. Giagnacovo, G. Rossi, L.V. Renna, E. Bugiardini, C. Pizzamiglio, A. Botta, G. Meola
Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction
2014 L.V. Renna, R. Cardani, A. Botta, G. Rossi, B. Fossati, E. Costa, G. Meola
Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2
2014 A. Perfetti, S. Greco, P. Fasanaro, E. Bugiardini, R. Cardani, J.M. Garcia Manteiga, M. Riba, D. Cittaro, E. Stupka, G. Meola, F. Martelli
Development and validation of a new molecular diagnostic assay for detection of myotonic dystrophy type 2
2015 R. Valaperta, F. Lombardi, R. Cardani, B. Fossati, E. Brigonzi, I. Merli, V. Sansone, G. Merletti, E. Spina, G. Meola, E. Costa
Myotonic dystrophies : an update on clinical aspects, genetic, pathology, and molecular pathomechanisms
2015 G. Meola, R. Cardani
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile